Lumigan 0.3mg/ml SD
*Company:
AbbVie LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 19 December 2024
File name
Lumigan 0.3 mgml eye drops, solution single-dose PIL.pdf
Reasons for updating
- Correction of spelling/typing errors
Updated on 19 December 2024
File name
Lumigan 0.3 mgml eye drops, solution single-dose SPC.pdf
Reasons for updating
- Correction of spelling/typing errors
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 22 November 2024
File name
Lumigan 0.3 mgml eye drops, solution single-dose SPC.pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
- Improved presentation of SPC
- Updated inline with QRD template and/or excipient guideline
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
To update the Product Information in line with the latest QRD template
Updated on 22 November 2024
File name
Lumigan 0.3 mgml eye drops, solution single-dose PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
To update the Product Information in line with the latest QRD template.
Updated on 22 November 2022
File name
Lumigan 0.3 UD SPC IE V9.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 22 November 2022
File name
ie-lumigan-pil-0.3UD-clean.pdf
Reasons for updating
- New PIL for new product